Prasugrel Tablets, USP, 5 mg, 30-count bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC 0378-5185-93
Published March 26, 2025 · Recall initiated: February 25, 2025
Summary
FDA records drug Class II recall D-0280-2025, published March 26, 2025 and initiated February 25, 2025. Recalling firm: MYLAN PHARMACEUTICALS INC; Status: Ongoing; Reported quantity: N/A; Lot: Lot # 3211073, 3211074, 3211075, Exp 4/30/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications - low dissolution results
What to do
Voluntary: Firm initiated · Letter
Get an email if PRASUGREL has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- PRASUGREL
- Manufacturer
- MYLAN PHARMACEUTICALS INC
- Distributor
- US Nationwide.
- UPC
- 0303785185932
- Lot
- Lot # 3211073, 3211074, 3211075, Exp 4/30/2026
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAPrasugrel HCI, Tablets, USP, 10mg, 30-count bottle, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CASeptember 9, 2026
- FDAPrasugrel Tablets, USP, 10mg, Rx only, 30 Tablets in each bottle, Manufactured for: Mylan PharmaceuticalsSeptember 9, 2026
- FDAPRASUGREL TABLETS, 5 mg, 30 tablet bottles, Rx only, packaged by GSMS, Incorporated, Camarillo, CA 93012 NDCMarch 26, 2025
- FDACinacalcet Hydrochloride Tablets 60 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus,March 26, 2025
- FDAVitality, Fast Acting Male Enhancement Product, Dietary Supplement, a) One Capsule per Packet, b) 6 capsulesMarch 26, 2025
- FDAPrasugrel Tablets 5 mg, 30-count bottles, Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WVNovember 6, 2019
Questions about this recall
Was Prasugrel Tablets, USP, 5 mg, 30-count bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC 0378-5185-93 recalled?
Yes. FDA published recall D-0280-2025 on March 26, 2025. Reported hazard: Failed Dissolution Specifications - low dissolution results
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: PRASUGREL. UPC: 0303785185932.